再発性Clostridioides difficile感染症の治療方法としての糞便微生物移植:有効性,安全性,作用メカニズム,結果のレビュー
Chukwuka Elendu1, Eunice K Omeludike2, Eunice T Aregbesola3
1Department of Medicine, Federal University Teaching Hospital, Owerri, Nigeria.
Annals of medicine and surgery (2012)
|September 3, 2025
まとめ
糞便微生物移植 (FMT) は,80%以上の成功率で腸内細菌を回復させることで,再発性Clostridioides difficile感染 (rCDI) を効果的に治療します. 継続的な研究は,安全性,標準化,およびFMTの拡大に焦点を当てています.
科学分野:
- 胃腸学と微生物学
- 感染症
- 微生物群の治療法
背景:
- 再発性Clostridioides difficile感染 (rCDI) は,標準的な抗生物質治療後に高い再発率で,世界的な健康負担を伴う.
- 抗生物質の使用は腸内微生物群を破壊し,C. difficileの増殖とその後の感染の経路を生み出します.
- 既存の治療法ではしばしば rCDIを予防できず,代替治療戦略の必要性を強調しています.
研究 の 目的:
- 再発したC. difficile感染に対する変容療法としての糞便微生物移植 (FMT) の評価.
- FMTが腸内ホメオスタシスを回復する仕組みを調査する.
- rCDI治療におけるFMTの課題に対処し,将来の方向性を探求する.
主な方法:
- rCDIの糞便微生物移植に関する臨床試験と新たな証拠のレビュー
- 腸内微生物群の組成,多様性,機能に対するFMTの影響の分析
- FMTの安全性プロファイル,配送の革新,規制の検討
主要な成果:
- 糞便の微生物移植 (FMT) は,rCDIの高い成功率 (80%を超える) を示し,抗生物質を大幅に上回っている.
- FMTは腸内微生物の多様性を回復し,胆酸代謝を調節し,短鎖脂肪酸の産生を促進します.
- 口服カプセルのようなイノベーションは FMTのアクセシビリティを向上させていますが,安全性と標準化は依然として重要な問題です.
結論:
- 糞便微生物移植 (FMT) は,再発性C. difficile感染 (rCDI) に対する非常に効果的な治療法であり,抗生物質の有効な代替手段である.
- 持続的な有効性と安全性のために,ドナー選択,規制枠組み,個別化されたFMTアプローチを最適化するためにさらなる研究が必要です.
- FMTは,rCDI以外にも,他のディスバイオシス関連疾患の治療に有望であり,継続的な調査を正当化しています.
関連する概念動画
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
201
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
201
Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
201
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
201


